Effectiveness and Tolerability of CV-3988, a Selective PAF Antagonist, After Intravenous Administration to Man.
British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/j.1365-2125.1988.tb03328.x
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 1988
Authors
Publisher
Wiley